Reconsidering Dexmedetomidine for Sedation in the Critically Ill: Implications of the SPICE III Trial

Annals of Pharmacotherapy - United States
doi 10.1177/1060028019890672
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications